A Testament To Biopharma’s Transparent Leaders: And A Previously Unpublished Regeneron Article Sidebar
Rob Wright discusses the unusual genesis of the Regeneron Genetics Center (RGC). Continue Reading..
The R&D Leadership Summit 2018 — One Hot Ticket
The Conference Forum’s 2018 R&D Leadership Summit employs the Chatham House Rule, which limits what information can be revealed from the event's proceedings. As one of the only members of the media in the room, Chief Editor Rob Wright shares what he can from this year's event, which had the theme “Growth: Where Will It Come From?” Continue Reading..
J&J’s Addition Of JLABS in New York City Creates Buzz At BIO CEO 2018
Rob Wright interviews Kate Merton, head of Johnson & Johnson Innovation’s newly created JLABS in New York City. Continue Reading..
Jeremy Levin On BIO’s Efforts Toward Tackling The Opioid Crisis
Rob Wright interviews Jeremy Levin, chairman and CEO of Ovid Therapeutics, about the BIO opioid crisis working group he is chairing. Continue Reading..
What Oppenheimer Is Doing To Support Healthcare Investors
Rob Wright video interviews Michael Margolis, R.Ph, head of life sciences and co-head of healthcare investment banking at Oppenheimer & Co. Inc. during the 2018 BIO CEO & Investor Conference in New York. Continue Reading..
Why CytoSorbents Has The BIO CEO Investor Community Buzzing
Rob Wright video interviews CytoSorbents’ CEO, Dr. Philip Chan, about CytoSorb, the company’s lead product described as a “Brita filter for your blood,” during the 2018 BIO CEO & Investor Conference in New York. Continue Reading..
Atreca Is Doing More Than Just Creating A Buzz At BIO CEO 2018
Rob Wright video interviews Atreca CEO, Tito Serafini, during the 2018 BIO CEO & Investor Conference in New York about the company’s search for antigens that are driving successful immune responses in cancer patients. Continue Reading..